GLP-1 receptor analogues (GLP-1 RAs) offer a promising therapeutic avenue, as they facilitate weight reduction, improve metabolic markers such as insulin sensitivity and lipid profiles, and also reduce the incidence of T2DM, which are more prevalent in women with PCOS. Here, GLP1R is linked to type 2 diabetes mellitus.